Article
Urologists across the country are reporting an average increase of 39% in their medical liability insurance rates for the most current premium year.
Expert discusses the promise of emerging MISTs for BPH
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
FDA Advisory Committee unanimously votes against talazoparib plus enzalutamide for mCRPC
FDA Advisory Committee finds evidence for UGN-102 inconclusive, cites uncertainty in benefit-risk
2 Commerce Drive
Cranbury, NJ 08512